Alkermes Inc. plc (ALKS) is a publicly traded Healthcare sector company. As of July 14, 2026, ALKS trades at $51.86 with a market cap of $8.66B and a P/E ratio of 55.54. ALKS moved -0.17% today. Year to date, ALKS is +86.52%; over the trailing twelve months it is +71.30%. Its 52-week range spans $25.17 to $55.67. Analyst consensus is strong buy with an average price target of $52.25. Rallies surfaces ALKS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ALKS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $51.86 |
| Market Cap | $8.66B |
| P/E Ratio | 55.54 |
| EPS | $0.93 |
| Dividend Yield | 0.00% |
| 52-Week High | $55.67 |
| 52-Week Low | $25.17 |
| Volume | 1.31M |
| Avg Volume | 0 |
| Revenue (TTM) | $1.56B |
| Net Income | $152.72M |
| Gross Margin | 86.63% |
12 analysts cover ALKS: 0 strong buy, 10 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $52.25.